Multiple Sclerosis Discovery Forum
  News and Future Directions
  Papers
  Forums
  Professional Resources
  Research Resources
MSGene - Gene overview of all published MS-association studies for STAT3
Back Search Methods Disclaimer Credits
 Gene: STAT3 (APRF; FLJ20882; HIES; MGC16063)
 Protein: signal transducer and activator of transcription 3 (acute-phase response factor)(DNA-binding protein APRF; acute-phase response factor; signal transducer and activator of transcription 3)
 Chromosome: 17   (View: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X  Y  MT)
 Status: Updated 5 March 2012
Meta-Analysis
1. Case-Control Studies (by ethnic group)
      MS Cases Normal Controls  
Study Population Source # Polys # Subjects
(% women)		 DX Onset Age
(range)		 Age
(range)		 # Subjects
(% women)		 Age
(range)		 Result
 Caucasian
Aulchenko, 2008
 Netherlands (GWAS) CL  1  (detail)  45
(-)		O/M--195
(-)		-Negative
Baranzini, 2008
 Overlaps with
Jakkula, 2010 (GeneMSA)		 CL  1  (detail)  978
(67%)		MD1&234
(11-61)		47
(21-69)		883
(66%)		46
(21-69)		n.a.
Cenit, 2010
 Spain CL  3  (detail)  1540
(-)		P29 + 9
(-)		-1720
(-)		-Negative
Comabella, 2008
 Spain (REP) CL  1  (detail)  100
(67%)		P-41.8 + 10.3
(-)		100
(65%)		42.9 + 12.6
(-)		Negative
Comabella, 2008
 Spain (GWAS, pooled) CL  1  (detail)  242
(67%)		P-43.5 + 11
(-)		242
(65%)		43.9 + 12.3
(-)		Positive
IMSGC, 2007
 USA, UK (GWAS) CL,PO  1  (detail)  931
(75%)		MD1&227.8
(10-51)		38.6
(17-59)		2431
(-)		-Negative
IMSGC, 2007
 Overlaps with
Jakkula, 2010 (IMSGC)		 CL,PO  2  (detail)  931
(75%)		MD1&227.8
(10-51)		38.6
(17-59)		2431
(-)		-Negative
IMSGC, 2011
 Europe, USA, Australia, New Zealand (WTCCC2-GWAS) CL,PO  1  (detail)  9722
(-)		U32.3
(-)		44.8
(-)		17376
(-)		-Positive
IMSGC, 2011
 Netherlands (GeneMSA-GWAS) CL  1  (detail)  230
(74%)		U33
(-)		46
(-)		232
(-)		-Positive
IMSGC, 2011
 USA (GeneMSA-GWAS) CL  1  (detail)  486
(76%)		U33
(-)		48
(-)		431
(-)		-Positive
IMSGC, 2011
 Switzerland (GeneMSA-GWAS) CL  1  (detail)  253
(74%)		U33
(-)		45
(-)		208
(-)		-Positive
IMSGC, 2011
 Australia, New Zealand (ANZ-GWAS) CL  1  (detail)  1618
(72%)		U34
(-)		-1988
(-)		-Positive
IMSGC, 2011
 USA (BWH-GWAS) CL  1  (detail)  973
(72%)		U33
(-)		47
(-)		2952
(-)		-Positive
IMSGC, 2011
 UK, USA (IMSGC2007-GWAS) CL,PO  1  (detail)  795
(76%)		U28
(-)		41
(-)		1679
(-)		-Positive
Jakkula, 2010
 Finland-isolate (GWAS) CL,PO  1  (detail)  68
(-)		O/M--136
(-)		-Positive
Jakkula, 2010
 Finland-isolate (Replication) CL,PO  1  (detail)  83
(-)		O/M--365
(-)		-Trend
Jakkula, 2010
 Finland-general (Replication) CL  1  (detail)  628
(-)		O/M--668
(-)		-Positive
Jakkula, 2010
 Norway (Replication) CL  1  (detail)  607
(-)		O/M--816
(-)		-Positive
Jakkula, 2010
 Denmark (Replication) CL  1  (detail)  628
(-)		MD1--1074
(-)		-Positive
Jakkula, 2010
 Switzerland (GeneMSA-GWAS) CL  1  (detail)  253
(-)		O/M--208
(-)		-Negative
Jakkula, 2010
 Netherlands (GeneMSA-GWAS) CL  1  (detail)  230
(-)		O/M--232
(-)		-Positive
Jakkula, 2010
 USA (GeneMSA-GWAS) CL  1  (detail)  486
(-)		O/M--431
(-)		-Positive
Jakkula, 2010
 UK (IMSGC-GWAS) CL,PO  1  (detail)  453
(-)		O/M--2950
(-)		-Negative
Jakkula, 2010
 USA (IMSGC-GWAS) CL  1  (detail)  342
(-)		O/M--1679
(-)		-Negative
Jakkula, 2010
 USA (BWH-GWAS) CL  1  (detail)  860
(-)		O/M--1720
(-)		-Positive
Lill, 2011
 Germany CL  2  (detail)  2932
(71%)		O/M-41 + 11.4
(-)		2972
(60%)		42 + 16.9
(-)		Positive
Sanna, 2010
 Italy-Sardinia (GWAS) CL  1  (detail)  882
(-)		MD1--872
(-)		-Negative
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
2. Family-Based Studies (by ethnic group)
      Affecteds Unaffecteds  
Study Population # Polys # Families # Subjects
(% women)		 DX Onset Age
(range)		 Age
(range)		 # Subjects
(% women)		 Age
(range)		 Result
 Caucasian
Bergkvist, 2004
 Sweden  1  (detail)  2757
(65%)		P--83
(46%)		-Negative
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:  Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:  Number of polymorphisms tested per gene and per sample.
Onset Age and Age:  Mean or median age at onset or examination, respectively.
DX:  Criteria used to determine MS diagnosis ->  "P" (Poser criteria, 1983), "MD1" (McDonald criteria, 2001), "MD2" (revised McDonald criteria, 2005), "MD1&2" (McDonald criteria, 2001 and 2005), "O/M" (other/mixed), "U" (Unknown).
Result:  Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between).
(-) :  Either no data provided or in case of overlap, data included in original study.
Print this page
Email this page
MSDF RSS

Text size
Share & Bookmark
MSGene Recent Updates
MSGene Top Results
Top Results Details
1. HLA-DRB1
2. IL2RA
3. IL7R
4. TAGAP
5. CLEC16A
6. EVI5
7. GWA_16q24.1
8. GWA_5p13.1
9. TTC34
10. AHI1   
[see more]
MSGene Stats
Studies: 789
Genes: 809
Polymorphisms: 2907
Meta-analyses: 324
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Copyright © 2024 Biomedical Research Forum LLC Disclaimer Copyright